Apogee Therapeutics Statistics
Total Valuation
APGE has a market cap or net worth of $3.15 billion. The enterprise value is $2.34 billion.
| Market Cap | 3.15B |
| Enterprise Value | 2.34B |
Important Dates
The last earnings date was Monday, May 13, 2024, before market open.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
APGE has 58.46 million shares outstanding. The number of shares has increased by 903.80% in one year.
| Shares Outstanding | 58.46M |
| Shares Change (YoY) | +903.80% |
| Shares Change (QoQ) | +100.71% |
| Owned by Insiders (%) | 11.36% |
| Owned by Institutions (%) | 121.43% |
| Float | 35.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.93 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 38.08, with a Debt / Equity ratio of 0.00.
| Current Ratio | 38.08 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -27.10% and return on invested capital (ROIC) is -14.76%.
| Return on Equity (ROE) | -27.10% |
| Return on Assets (ROA) | -23.20% |
| Return on Capital (ROIC) | -14.76% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$11.51M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 57.42 |
| 200-Day Moving Average | 33.34 |
| Relative Strength Index (RSI) | 52.68 |
| Average Volume (30 Days) | 720,993 |
Short Selling Information
The latest short interest is 4.84 million, so 8.29% of the outstanding shares have been sold short.
| Short Interest | 4.84M |
| Short Previous Month | 4.55M |
| Short % of Shares Out | 8.29% |
| Short % of Float | 13.73% |
| Short Ratio (days to cover) | 10.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -118.53M |
| Pretax Income | -103.55M |
| Net Income | -103.55M |
| EBITDA | -103.17M |
| EBIT | -103.55M |
| Earnings Per Share (EPS) | -$5.25 |
Balance Sheet
The company has $816.20 million in cash and $1.77 million in debt, giving a net cash position of $814.43 million or $13.93 per share.
| Cash & Cash Equivalents | 816.20M |
| Total Debt | 1.77M |
| Net Cash | 814.43M |
| Net Cash Per Share | $13.93 |
| Equity / Book Value | 801.48M |
| Book Value Per Share | 13.71 |
| Working Capital | 799.06M |
Cash Flow
In the last 12 months, operating cash flow was -$95.84 million and capital expenditures -$518,000, giving a free cash flow of -$96.36 million.
| Operating Cash Flow | -95.84M |
| Capital Expenditures | -518,000 |
| Free Cash Flow | -96.36M |
| FCF Per Share | -$1.92 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -903.80% |
| Shareholder Yield | -903.80% |
| Earnings Yield | -3.28% |
| FCF Yield | -3.06% |
Analyst Forecast
The average price target for APGE is $65.80, which is 22.42% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $65.80 |
| Price Target Difference | 22.42% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |